News Home

Should Biotechnology Stock Revolution Medicines Inc (RVMD) Be in Your Portfolio Wednesday?

Wednesday, September 28, 2022 03:42 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Revolution Medicines Inc (RVMD) Be in Your Portfolio Wednesday?

The 49 rating InvestorsObserver gives to Revolution Medicines Inc (RVMD) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 43 percent of stocks in the Biotechnology industry, RVMD’s 49 overall rating means the stock scores better than 49 percent of all stocks.

Overall Score - 49
RVMD has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on RVMD!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Revolution Medicines Inc Stock Today?

Revolution Medicines Inc (RVMD) stock is trading at $19.92 as of 3:42 PM on Wednesday, Sep 28, an increase of $1.06, or 5.62% from the previous closing price of $18.86. The stock has traded between $19.17 and $20.08 so far today. Volume today is low. So far 397,098 shares have traded compared to average volume of 863,810 shares. Click Here to get the full Stock Report for Revolution Medicines Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App